<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04221074</url>
  </required_header>
  <id_info>
    <org_study_id>N B in gynecomastia surgery</org_study_id>
    <nct_id>NCT04221074</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Modified Pectoral Plane Block Versus Erector Spinae Plane Block During GA in Gynecomastia Surgery</brief_title>
  <official_title>Ultrasound Guided Modified Pectoral Plane (PECS II )Block Versus Erector Spinae Plane (ESP) Block for Perioperative Analgesia of Surgical Treatment of Gynecomastia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain of breast surgery is due to chest wall scar and arm in some cases like carcinoma or due
      to nerve injury.It is neuropathic or nociceptive pain.Its severity is depending on the extent
      of surgery and the radiotherapy if needed.

      Previous studies proved that local nerve block procedures improved the immediate
      postoperative pain and decreased the incidence of postoperative pain chronicity .

      Also effective control of pain suppresses the surgical stress response minimizes the
      anaesthestic needs intraoperatively and decreases the opioid needs postoperatively .

      Pectoralis nerve(pecs) II block and erector spinae plane (ESP) block are novel procedures
      that may provide good intraoperative and postoperative analgesia in patients undergoing
      surgical treatment of gynecomastia.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative analgesia</measure>
    <time_frame>60-120 minuets</time_frame>
    <description>measurement of intraoperative mean blood pressure (mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>intraoperative analgesia</measure>
    <time_frame>60-120 minuets</time_frame>
    <description>measurement of heart rate (beat /min)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>intraoperative analgesia</measure>
    <time_frame>60-120 minuets</time_frame>
    <description>measurement of bispectral index score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative analgesia</measure>
    <time_frame>24 hours</time_frame>
    <description>evaluation of postoperative visual analogue scaleusing a ruler graded from 0 to 100 mm,where 0=no pain and 100=the worst imaginable pain measured in postanaesthesia care unit and every 6hours for 24 h postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative analgesia</measure>
    <time_frame>24 hours</time_frame>
    <description>time interval till first analgesic request (minuets)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative analgesia</measure>
    <time_frame>24 hours</time_frame>
    <description>total opioid consumption (mg)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">46</enrollment>
  <condition>Gynecomastia, Adolescent</condition>
  <arm_group>
    <arm_group_label>Modified Pectoral Plane (PECSII ) block (P)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>done after induction of general anaesthesia in supine position of the patient with his arm of the side of the operation abducted 90 degree with the probe with frequency L4-12t (Logiq e machine) at the midclavicular level and angled infero-laterally,the axillary artery and vein and the second rib identified the probe moved laterally until the pectoralis minor and serratus anterior are identified,the local anesthetic was injected at two points using (echoplext guge20 length 50 mm ) needle:the first injection of 10 ml of 0.25% Bupivacaine and 4 mg dexamethasone injected between the pectoralis major and minor muscles,and the second injection of 20 ml of 0.25% Bupivacaine and 4 mg dexamethasone between the pectoralis minor and serratus anterior muscles .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Erector Spinae Plane ( ESP )block (E)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>after induction of general anaesthesia in lateral position of the patient where the surgical side up and at T4 level the probe with frequency L4-12t (Logiq e machine) placed lateral to the spine by 3 cm in parasagittal plane the needle (echoplext guge20 length 50 mm ) advanced between the transverse process and the erector spinae muscle at that level 20 ml of 0.25% Bupivacaine and 8 mg dexamethasone injected.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PECS II versus ESP</intervention_name>
    <description>compare between :ultrasound guided Pectoralis nerve(pecs) II block or erector spinae plane (ESP) block in surgical treatment for gynecomastia patients under general anaesthesia.</description>
    <arm_group_label>Erector Spinae Plane ( ESP )block (E)</arm_group_label>
    <arm_group_label>Modified Pectoral Plane (PECSII ) block (P)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male gender .

          -  Age : 18 - 25 years old .

          -  Physical status : ASA I - II .

          -  Body mass index(BMI) :20-30 kg/m2

          -  Surgical treatment of Gynecomastia .

          -  Duration of surgery : 60 -120 min

        Exclusion Criteria:

          -  Patient refusal .

          -  History of opioid abuse or chronic analgesic use .

          -  Coagulopathy .

          -  Allergy to study drugs .

          -  Infection in the injection sites.

          -  Uncooperative patients.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Manal M rashad, MD</last_name>
    <phone>00201005671564</phone>
    <email>mervatassy@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anas A abdelhay, MD</last_name>
    <phone>00201221560351</phone>
    <email>dr_anas@msn.com</email>
  </overall_contact_backup>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 6, 2020</study_first_submitted>
  <study_first_submitted_qc>January 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2020</study_first_posted>
  <last_update_submitted>January 21, 2020</last_update_submitted>
  <last_update_submitted_qc>January 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>manal mohamed rashad</investigator_full_name>
    <investigator_title>lecturer of anaesthesia</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gynecomastia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

